TAMELA SWANSON: Open Payments
NPI 1326461773 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 58 payments from 13 companies in 2025. Trend: 2023 $1,877 · 2024 $2,057 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $282 |
| Otsuka America Pharmaceutical, Inc. | 10 | $248 |
| Vanda Pharmaceuticals Inc. | 9 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $134 |
| Alkermes, Inc. | 5 | $112 |
| Teva Pharmaceuticals USA, Inc. | 3 | $82 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| Corium, LLC | 2 | $26 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
Products named: VRAYLAR, REXULTI, CAPLYTA, FANAPT, ARISTADA, UZEDY, Auvelity, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
